IRVINE, Calif.--(BUSINESS WIRE)--To support increasing demand globally for COVID-19 testing, BioDot has compressed production times for most new lateral flow dispensing platforms from months to four ...
Biodot, which started operations in 1994, manufactures automated ultra-low-volume fluid dispensing systems for labs that make antibody or serology tests. These tests are indicators of immune responses ...
BioDot Inc. of Irvine had plans to scale in 2020. It didn’t anticipate a global pandemic, which drove demand higher than ever before for its ultra low-volume dispensers that are used to dispense ...
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth IRVINE, ...
The need for accessible, convenient and rapid testing over the course of the pandemic pushed the FDA to temporarily approve over-the-counter COVID-19 tests. That’s one result of the past year that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results